XML 89 R76.htm IDEA: XBRL DOCUMENT v3.7.0.1
Guarantor Financial Information - Condensed Consolidating Statement of Cash Flows (Details) - USD ($)
$ in Millions
 3 Months Ended
Jul. 28, 2017
Jul. 29, 2016
Operating Activities:    
Net cash provided by (used in) operating activities $ 737 $ 1,550
Investing Activities:    
Acquisitions, net of cash acquired 0 (12)
Additions to property, plant, and equipment (278) (330)
Purchases of investments (615) (1,044)
Sales and maturities of investments 971 1,104
Net (increase) decrease in intercompany loans 0 0
Capital contribution paid 0 0
Other investing activities, net 5 (2)
Net cash provided by (used in) investing activities 83 (284)
Financing Activities:    
Acquisition-related contingent consideration (3) (11)
Change in current debt obligations, net 569 926
Issuance of long-term debt 18 33
Payments on long-term debt (8) (17)
Dividends to shareholders (625) (599)
Issuance of ordinary shares 143 214
Repurchase of ordinary shares (1,233) (1,763)
Net intercompany loan borrowings (repayments) 0 0
Intercompany dividend paid 0  
Capital contribution received 0 0
Other financing activities (2) 57
Net cash used in financing activities (1,141) (1,160)
Effect of exchange rate changes on cash and cash equivalents 45 78
Net change in cash and cash equivalents (276) 184
Cash and cash equivalents at beginning of period 4,967 2,876
Cash and cash equivalents at end of period 4,691 3,060
Consolidating Adjustments | Medtronic Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities 0 0
Investing Activities:    
Acquisitions, net of cash acquired 0 0
Additions to property, plant, and equipment 0 0
Purchases of investments 0 162
Sales and maturities of investments 0 (162)
Net (increase) decrease in intercompany loans (2,504) 3,113
Capital contribution paid   162
Other investing activities, net 0 0
Net cash provided by (used in) investing activities (2,504) 3,275
Financing Activities:    
Acquisition-related contingent consideration 0 0
Change in current debt obligations, net 0 0
Issuance of long-term debt 0 0
Payments on long-term debt 0 0
Dividends to shareholders 0 0
Issuance of ordinary shares 0 0
Repurchase of ordinary shares 0 0
Net intercompany loan borrowings (repayments) 2,504 (3,113)
Intercompany dividend paid 0  
Capital contribution received   (162)
Other financing activities 0 0
Net cash used in financing activities 2,504 (3,275)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Consolidating Adjustments | CIFSA Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities (250) 0
Investing Activities:    
Acquisitions, net of cash acquired 0 0
Additions to property, plant, and equipment 0 0
Purchases of investments 0 0
Sales and maturities of investments 0 0
Net (increase) decrease in intercompany loans 3,198 (5,850)
Capital contribution paid 452 325
Other investing activities, net 0 0
Net cash provided by (used in) investing activities 3,650 (5,525)
Financing Activities:    
Acquisition-related contingent consideration 0 0
Change in current debt obligations, net 0 0
Issuance of long-term debt 0 0
Payments on long-term debt 0 0
Dividends to shareholders 0 0
Issuance of ordinary shares 0 0
Repurchase of ordinary shares 0 0
Net intercompany loan borrowings (repayments) (3,198) 5,850
Intercompany dividend paid 250  
Capital contribution received (452) (325)
Other financing activities 0 0
Net cash used in financing activities (3,400) 5,525
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Medtronic plc | Medtronic Senior Notes    
Financing Activities:    
Intercompany dividend paid 0  
Medtronic plc | CIFSA Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities   440
Investing Activities:    
Acquisitions, net of cash acquired   0
Additions to property, plant, and equipment   0
Purchases of investments   0
Sales and maturities of investments   0
Net (increase) decrease in intercompany loans   0
Capital contribution paid   0
Other investing activities, net   0
Net cash provided by (used in) investing activities   0
Financing Activities:    
Acquisition-related contingent consideration   0
Change in current debt obligations, net   0
Issuance of long-term debt   0
Payments on long-term debt   0
Dividends to shareholders   (599)
Issuance of ordinary shares   214
Repurchase of ordinary shares   (1,763)
Net intercompany loan borrowings (repayments)   1,708
Capital contribution received   0
Other financing activities   0
Net cash used in financing activities   (440)
Effect of exchange rate changes on cash and cash equivalents   0
Net change in cash and cash equivalents   0
Cash and cash equivalents at beginning of period   0
Cash and cash equivalents at end of period   0
Medtronic plc | Reportable Legal Entities | Medtronic Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities 24 440
Investing Activities:    
Acquisitions, net of cash acquired 0 0
Additions to property, plant, and equipment 0 0
Purchases of investments 0 0
Sales and maturities of investments 0 0
Net (increase) decrease in intercompany loans 0 0
Capital contribution paid   0
Other investing activities, net 0 0
Net cash provided by (used in) investing activities 0 0
Financing Activities:    
Acquisition-related contingent consideration 0 0
Change in current debt obligations, net 0 0
Issuance of long-term debt 0 0
Payments on long-term debt 0 0
Dividends to shareholders (625) (599)
Issuance of ordinary shares 143 214
Repurchase of ordinary shares (1,233) (1,763)
Net intercompany loan borrowings (repayments) 1,691 1,708
Capital contribution received   0
Other financing activities 0 0
Net cash used in financing activities (24) (440)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period 0 0
Medtronic plc | Reportable Legal Entities | CIFSA Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities 24  
Investing Activities:    
Acquisitions, net of cash acquired 0  
Additions to property, plant, and equipment 0  
Purchases of investments 0  
Sales and maturities of investments 0  
Net (increase) decrease in intercompany loans 0  
Capital contribution paid 0  
Other investing activities, net 0  
Net cash provided by (used in) investing activities 0  
Financing Activities:    
Acquisition-related contingent consideration 0  
Change in current debt obligations, net 0  
Issuance of long-term debt 0  
Payments on long-term debt 0  
Dividends to shareholders (625)  
Issuance of ordinary shares 143  
Repurchase of ordinary shares (1,233)  
Net intercompany loan borrowings (repayments) 1,691  
Intercompany dividend paid 0  
Capital contribution received 0  
Other financing activities 0  
Net cash used in financing activities (24)  
Effect of exchange rate changes on cash and cash equivalents 0  
Net change in cash and cash equivalents 0  
Cash and cash equivalents at beginning of period 0  
Cash and cash equivalents at end of period 0  
Subsidiary Issuer | Medtronic Senior Notes    
Financing Activities:    
Intercompany dividend paid 0  
Subsidiary Issuer | CIFSA Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities   (7)
Investing Activities:    
Acquisitions, net of cash acquired   0
Additions to property, plant, and equipment   0
Purchases of investments   0
Sales and maturities of investments   0
Net (increase) decrease in intercompany loans   4,290
Capital contribution paid   (325)
Other investing activities, net   0
Net cash provided by (used in) investing activities   3,965
Financing Activities:    
Acquisition-related contingent consideration   0
Change in current debt obligations, net   0
Issuance of long-term debt   0
Payments on long-term debt   0
Dividends to shareholders   0
Issuance of ordinary shares   0
Repurchase of ordinary shares   0
Net intercompany loan borrowings (repayments)   (4,081)
Capital contribution received   0
Other financing activities   0
Net cash used in financing activities   (4,081)
Effect of exchange rate changes on cash and cash equivalents   0
Net change in cash and cash equivalents   (123)
Cash and cash equivalents at beginning of period   208
Cash and cash equivalents at end of period   85
Subsidiary Issuer | Reportable Legal Entities | Medtronic Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities (355) 534
Investing Activities:    
Acquisitions, net of cash acquired 0 0
Additions to property, plant, and equipment (68) 0
Purchases of investments 0 0
Sales and maturities of investments 0 162
Net (increase) decrease in intercompany loans 431 (541)
Capital contribution paid   (162)
Other investing activities, net 0 0
Net cash provided by (used in) investing activities 363 (541)
Financing Activities:    
Acquisition-related contingent consideration 0 0
Change in current debt obligations, net 0 0
Issuance of long-term debt 0 0
Payments on long-term debt 0 0
Dividends to shareholders 0 0
Issuance of ordinary shares 0 0
Repurchase of ordinary shares 0 0
Net intercompany loan borrowings (repayments) 10 (2)
Capital contribution received   0
Other financing activities 0 0
Net cash used in financing activities 10 (2)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 18 (9)
Cash and cash equivalents at beginning of period 45 55
Cash and cash equivalents at end of period 63 46
Subsidiary Issuer | Reportable Legal Entities | CIFSA Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities 234  
Investing Activities:    
Acquisitions, net of cash acquired 0  
Additions to property, plant, and equipment 0  
Purchases of investments 0  
Sales and maturities of investments 0  
Net (increase) decrease in intercompany loans 183  
Capital contribution paid (452)  
Other investing activities, net 0  
Net cash provided by (used in) investing activities (269)  
Financing Activities:    
Acquisition-related contingent consideration 0  
Change in current debt obligations, net 0  
Issuance of long-term debt 0  
Payments on long-term debt 0  
Dividends to shareholders 0  
Issuance of ordinary shares 0  
Repurchase of ordinary shares 0  
Net intercompany loan borrowings (repayments) 2  
Intercompany dividend paid 0  
Capital contribution received 0  
Other financing activities 0  
Net cash used in financing activities 2  
Effect of exchange rate changes on cash and cash equivalents 0  
Net change in cash and cash equivalents (33)  
Cash and cash equivalents at beginning of period 33  
Cash and cash equivalents at end of period 0  
Subsidiary Guarantors | Medtronic Senior Notes    
Financing Activities:    
Intercompany dividend paid 0  
Subsidiary Guarantors | CIFSA Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities   0
Investing Activities:    
Acquisitions, net of cash acquired   0
Additions to property, plant, and equipment   0
Purchases of investments   0
Sales and maturities of investments   0
Net (increase) decrease in intercompany loans   (1,774)
Capital contribution paid   0
Other investing activities, net   0
Net cash provided by (used in) investing activities   (1,774)
Financing Activities:    
Acquisition-related contingent consideration   0
Change in current debt obligations, net   975
Issuance of long-term debt   0
Payments on long-term debt   0
Dividends to shareholders   0
Issuance of ordinary shares   0
Repurchase of ordinary shares   0
Net intercompany loan borrowings (repayments)   854
Capital contribution received   0
Other financing activities   0
Net cash used in financing activities   1,829
Effect of exchange rate changes on cash and cash equivalents   0
Net change in cash and cash equivalents   55
Cash and cash equivalents at beginning of period   0
Cash and cash equivalents at end of period   55
Subsidiary Guarantors | Reportable Legal Entities | Medtronic Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities 86 13
Investing Activities:    
Acquisitions, net of cash acquired 0 0
Additions to property, plant, and equipment 0 0
Purchases of investments 0 0
Sales and maturities of investments 0 0
Net (increase) decrease in intercompany loans (2,007) (1,787)
Capital contribution paid   0
Other investing activities, net 0 0
Net cash provided by (used in) investing activities (2,007) (1,787)
Financing Activities:    
Acquisition-related contingent consideration 0 0
Change in current debt obligations, net 572 975
Issuance of long-term debt 0 0
Payments on long-term debt 0 0
Dividends to shareholders 0 0
Issuance of ordinary shares 0 0
Repurchase of ordinary shares 0 0
Net intercompany loan borrowings (repayments) 1,373 854
Capital contribution received   0
Other financing activities 0 0
Net cash used in financing activities 1,945 1,829
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 24 55
Cash and cash equivalents at beginning of period 5 0
Cash and cash equivalents at end of period 29 55
Subsidiary Guarantors | Reportable Legal Entities | CIFSA Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities 88  
Investing Activities:    
Acquisitions, net of cash acquired 0  
Additions to property, plant, and equipment 0  
Purchases of investments 0  
Sales and maturities of investments 0  
Net (increase) decrease in intercompany loans (2,007)  
Capital contribution paid 0  
Other investing activities, net 0  
Net cash provided by (used in) investing activities (2,007)  
Financing Activities:    
Acquisition-related contingent consideration 0  
Change in current debt obligations, net 572  
Issuance of long-term debt 0  
Payments on long-term debt 0  
Dividends to shareholders 0  
Issuance of ordinary shares 0  
Repurchase of ordinary shares 0  
Net intercompany loan borrowings (repayments) 1,372  
Intercompany dividend paid 0  
Capital contribution received 0  
Other financing activities 0  
Net cash used in financing activities 1,944  
Effect of exchange rate changes on cash and cash equivalents 0  
Net change in cash and cash equivalents 25  
Cash and cash equivalents at beginning of period 5  
Cash and cash equivalents at end of period 30  
Subsidiary Non-guarantors | Medtronic Senior Notes    
Financing Activities:    
Intercompany dividend paid 0  
Subsidiary Non-guarantors | CIFSA Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities   1,117
Investing Activities:    
Acquisitions, net of cash acquired   (12)
Additions to property, plant, and equipment   (330)
Purchases of investments   (1,044)
Sales and maturities of investments   1,104
Net (increase) decrease in intercompany loans   3,334
Capital contribution paid   0
Other investing activities, net   (2)
Net cash provided by (used in) investing activities   3,050
Financing Activities:    
Acquisition-related contingent consideration   (11)
Change in current debt obligations, net   (49)
Issuance of long-term debt   33
Payments on long-term debt   (17)
Dividends to shareholders   0
Issuance of ordinary shares   0
Repurchase of ordinary shares   0
Net intercompany loan borrowings (repayments)   (4,331)
Capital contribution received   325
Other financing activities   57
Net cash used in financing activities   (3,993)
Effect of exchange rate changes on cash and cash equivalents   78
Net change in cash and cash equivalents   252
Cash and cash equivalents at beginning of period   2,668
Cash and cash equivalents at end of period   2,920
Subsidiary Non-guarantors | Reportable Legal Entities | Medtronic Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities 982 563
Investing Activities:    
Acquisitions, net of cash acquired 0 (12)
Additions to property, plant, and equipment (210) (330)
Purchases of investments (615) (1,206)
Sales and maturities of investments 971 1,104
Net (increase) decrease in intercompany loans 4,080 (785)
Capital contribution paid   0
Other investing activities, net 5 (2)
Net cash provided by (used in) investing activities 4,231 (1,231)
Financing Activities:    
Acquisition-related contingent consideration (3) (11)
Change in current debt obligations, net (3) (49)
Issuance of long-term debt 18 33
Payments on long-term debt (8) (17)
Dividends to shareholders 0 0
Issuance of ordinary shares 0 0
Repurchase of ordinary shares 0 0
Net intercompany loan borrowings (repayments) (5,578) 553
Capital contribution received   162
Other financing activities (2) 57
Net cash used in financing activities (5,576) 728
Effect of exchange rate changes on cash and cash equivalents 45 78
Net change in cash and cash equivalents (318) 138
Cash and cash equivalents at beginning of period 4,917 2,821
Cash and cash equivalents at end of period 4,599 $ 2,959
Subsidiary Non-guarantors | Reportable Legal Entities | CIFSA Senior Notes    
Operating Activities:    
Net cash provided by (used in) operating activities 641  
Investing Activities:    
Acquisitions, net of cash acquired 0  
Additions to property, plant, and equipment (278)  
Purchases of investments (615)  
Sales and maturities of investments 971  
Net (increase) decrease in intercompany loans (1,374)  
Capital contribution paid 0  
Other investing activities, net 5  
Net cash provided by (used in) investing activities (1,291)  
Financing Activities:    
Acquisition-related contingent consideration (3)  
Change in current debt obligations, net (3)  
Issuance of long-term debt 18  
Payments on long-term debt (8)  
Dividends to shareholders 0  
Issuance of ordinary shares 0  
Repurchase of ordinary shares 0  
Net intercompany loan borrowings (repayments) 133  
Intercompany dividend paid (250)  
Capital contribution received 452  
Other financing activities (2)  
Net cash used in financing activities 337  
Effect of exchange rate changes on cash and cash equivalents 45  
Net change in cash and cash equivalents (268)  
Cash and cash equivalents at beginning of period 4,929  
Cash and cash equivalents at end of period $ 4,661